Search company, investor...

Predict your next investment

Public-Private Partnership
stw.nl

Investments

11

Portfolio Exits

2

Partners & Customers

2

About Technology Foundation STW

Technology Foundation STW can trace its roots back to the programme for Technical Physics and Innovation initiated by the FOM Foundation at the end of the 1970s. In 1981 STW was officially established as a foundation to serve the entire spectrum of technical sciences. Since then the foundation's objective has been to realise knowledge transfer from excellent technical scientific research. Several years ago the emphasis in the mission was changed to knowledge transfer between the technical sciences and users so as to emphasise the role of the users in all STW projects. During the research projects users provide valuable recommendations and contribute their own knowledge, which can lead to a tightening of the research question. Ultimately innovation – or in STW terms utilisation – is the result of the joint efforts between researchers and users.

Headquarters Location

Van Vollenhovenlaan 661

Utrecht, 3527 JP,

Netherlands

+31 (0)30 6001 211

Want to inform investors similar to Technology Foundation STW about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Technology Foundation STW News

STW grants of €250k each for eight scientific startups - StartupJuncture

Jan 19, 2015

Suzanne Blotenburg 14 January, 2015 News The Dutch Ministry of Economic Affairs and the Ministry of Education, Culture and Science have granted the so-called STW grants. Eight startups received a sum of 250.000 euro each to turn their scientific ideas into commercial success. Technology Foundation STW realises the transfer of knowledge between the technical sciences and users. It does this by funding excellent technical scientific research and by bringing researchers and users together in each project. 3DPPM, MyLife Technologies, SolarSwing Energy, LUMICKS, ARTPred, Nerdalize, Oncodrone and Madam Therapeutics received a quarter million. Another 31 companies received a smaller amount of 40.000 euro’s. “The startups that receive this grant have proven the ability to transfer valuable academic research into economic and social value”, says Secretary of State Sander Dekker. Proposals for the grants were judged by research organisations STW, ZonMw and NOW, whom specifically paid attention to scientific innovation and commercial perspectives of the involved startups as well as the teams and links to the universities. 3DPPM 3DPPM (University of Eindhoven) produces recycled thermoplastic powders for improved SLS 3D printing. Currently over 90 percent of the powder used goes to waste. With this technology more than 50 percent can be reused. MyLife Technologies MyLife Technologies (University of Twente) develops novel microneedle arrays for transdermal transport. The micro needles offer advantages over classical neeldes and the potential for integration with analysis or smart delivery systems allows for faster, more accurate medical care. SolarSwing Energy SolarSwing (University of Nijmegen) combines effective solar control with high solar power production using efficient solar cells. The SolarSwing uses the sun in favor of the building: diffuse light enters as daylight while all direct light is turned into useful energy. LUMICKS LUMICKS is a spin-off from the VU University in Amsterdam, bringing to market a revolutionary technology enabling to produce videos of DNA-protein interactions at the single molecule level, which is key to e.g. cancer research. ARTPred Researchers at Erasmus MC have investigated that quantitative analysis of urine microbiome, can predict embryo implantation failure with 96 perdent accuracy. It is ARTPred’s objective to develop a clinically validated robust test that can predict failure of implantation of an embryo produced by IVF. Nerdalize Nerdalize (University of Groningen) heats buildings with existing computer power. By using the same energy twice, Nerdalize energizes houses for free whilst selling the generated computing power to clients. Oncodrone Oncodrone (RadboudUMC ) is a life sciences company developing novel therapeutics for epithelial derived malignancies including prostate-, breast-, lung-, pancreas- and bladder cancer. Madam Therapeutics Madam (LUMC and AMC) is an acronym for Molecular Anti-infective Drugs from Amsterdam. A privately held research-based biotechnology company which develops and commercializes a proprietary new class of antibiotics called cidins. Share this:

Technology Foundation STW Investments

11 Investments

Technology Foundation STW has made 11 investments. Their latest investment was in Pamyra as part of their Series A on April 4, 2020.

CBI Logo

Technology Foundation STW Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/28/2020

Series A

Pamyra

Yes

1

6/26/2017

Grant

Nico.lab

$0.27M

Yes

1

1/2/2016

Grant

Sleep.AI

$0.28M

Yes

1

1/14/2015

Grant

Subscribe to see more

$99M

Subscribe to see more

10

1/14/2015

Grant

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/28/2020

6/26/2017

1/2/2016

1/14/2015

1/14/2015

Round

Series A

Grant

Grant

Grant

Grant

Company

Pamyra

Nico.lab

Sleep.AI

Subscribe to see more

Subscribe to see more

Amount

$0.27M

$0.28M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

1

10

10

Technology Foundation STW Portfolio Exits

2 Portfolio Exits

Technology Foundation STW has 2 portfolio exits. Their latest portfolio exit was Nerdalize on February 27, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/27/2019

Asset Sale

$99M

1

4/10/2018

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/27/2019

4/10/2018

Exit

Asset Sale

Acquired

Companies

Subscribe to see more

Valuation

$99M

$99M

Acquirer

Subscribe to see more

Sources

1

10

Technology Foundation STW Partners & Customers

2 Partners and customers

Technology Foundation STW has 2 strategic partners and customers. Technology Foundation STW recently partnered with Singulex on April 4, 2015.

Date

Type

Business Partner

Country

News Snippet

Sources

4/30/2015

Partner

United States

Singulex Announces Partnership With The Dutch Technology Foundation (STW) to Accelerate the Development of Clinical Biomarkers

ALAMEDA , Calif. , April 30 , 2015 -- Singulex , Inc. , the developer and leading provider of Single Molecule Counting technology for clinical diagnostics and scientific discovery , today announced that it has entered into a public-private partnership with the Dutch Technology Foundation to form the Biomarker Development Center with the mission of accelerating the development and validation of clinical biomarkers .

3

1/19/2012

Partner

Netherlands

Subscribe to see more

Subscribe to see more

10

Date

4/30/2015

1/19/2012

Type

Partner

Partner

Business Partner

Country

United States

Netherlands

News Snippet

Singulex Announces Partnership With The Dutch Technology Foundation (STW) to Accelerate the Development of Clinical Biomarkers

ALAMEDA , Calif. , April 30 , 2015 -- Singulex , Inc. , the developer and leading provider of Single Molecule Counting technology for clinical diagnostics and scientific discovery , today announced that it has entered into a public-private partnership with the Dutch Technology Foundation to form the Biomarker Development Center with the mission of accelerating the development and validation of clinical biomarkers .

Subscribe to see more

Subscribe to see more

Sources

3

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.